Medicare Enrolled

Dr. Emily Guerrero, APRN

Nurse Practitioner - Adult Health · Naples, FL
Low-engagement
708 GOODLETTE RD, Naples, FL 34102
2392317260
In practice since 2019 (6 years)
NPI: 1285282186 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Guerrero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guerrero? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Guerrero

Dr. Emily Guerrero is a nurse practitioner - adult health in Naples, FL, with 6 years in practice.

Between the years covered by Open Payments, Dr. Guerrero received a total of $9,400 from 74 pharmaceutical and/or device companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Guerrero is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice$ $9,400 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$9,400
Total received (2021-2024)
Avg $2,350/year across 4 years
Top 3% in FL for nurse practitioner - adult health
74
Companies
443
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,400 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,987
2023
$2,235
2022
$2,213
2021
$1,964

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$672
Incyte Corporation
$635
Novartis Pharmaceuticals Corporation
$529
E.R. Squibb & Sons, L.L.C.
$494
Amgen Inc.
$488
Daiichi Sankyo Inc.
$450
PFIZER INC.
$387
Celgene Corporation
$364
Gilead Sciences, Inc.
$292
Takeda Pharmaceuticals U.S.A., Inc.
$261
Janssen Biotech, Inc.
$247
Merck Sharp & Dohme LLC
$234
GlaxoSmithKline, LLC.
$202
Eisai Inc.
$187
Regeneron Healthcare Solutions, Inc.
$175
BeiGene USA, Inc.
$175
Seagen Inc.
$161
Lilly USA, LLC
$161
JAZZ PHARMACEUTICALS INC.
$141
TAIHO ONCOLOGY, INC.
$133
ARRAY BIOPHARMA INC
$129
Alexion Pharmaceuticals, Inc.
$124
Bayer Healthcare Pharmaceuticals Inc.
$117
Myriad Genetic Laboratories, Inc.
$114
Ipsen Biopharmaceuticals, Inc
$114
Astellas Pharma US Inc
$112
Alnylam Pharmaceuticals Inc.
$111
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Kyowa Kirin, Inc.
$99
TerSera Therapeutics LLC
$99
Genentech USA, Inc.
$98
ABBVIE INC.
$95
Fennec Pharmaceuticals, Inc.
$88
CTI BioPharma Corp.
$86
SOBI, INC
$84
Pharmacosmos Therapeutics Inc.
$80
Genmab U.S., Inc.
$79
EISAI INC.
$72
Agios Pharmaceuticals, Inc.
$69
Pharmacyclics LLC, An AbbVie Company
$65
Bayer HealthCare Pharmaceuticals Inc.
$61
Deciphera Pharmaceuticals Inc.
$60
Kite Pharma, Inc.
$56
Sumitomo Pharma America, Inc.
$53
GENZYME CORPORATION
$49
Pharmacyclics LLC, an AbbVie Company
$48
Exelixis Inc.
$46
PUMA BIOTECHNOLOGY, INC.
$46
AMAG Pharmaceuticals, Inc.
$41
Dova Pharmaceuticals
$41
EMD Serono, Inc.
$37
Janssen Pharmaceuticals, Inc
$35
AVEO Pharmaceuticals, Inc.
$35
PharmaEssentia USA Corporation
$34
ADC Therapeutics America, Inc.
$33
Tempus AI, Inc
$32
Blueprint Medicines Corporation
$31
Apellis Pharmaceuticals, Inc.
$31
Stemline Therapeutics Inc.
$28
Mirati Therapeutics, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$23
Foundation Medicine, Inc.
$21
Epizyme, Inc.,
$21
Dendreon Pharmaceuticals LLC
$20
Aveo Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme Corporation
$20
Servier Pharmaceuticals LLC
$19
Sobi, Inc
$18
Acrotech Biopharma LLC
$17
Taiho Oncology, Inc.
$17
Acrotech Biopharma Inc.
$16
Karyopharm Therapeutics Inc.
$16
Myovant Sciences Inc.
$15
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 19.5% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADVATE · ALUNBRIG · ANDEXXA · AYVAKIT · Alecensa · BAVENCIO · BELEODAQ · BESREMI · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CERDELGA · COSELA · DARZALEX · DOPTELET · Doptelet · ENHERTU · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · FERAHEME · FOTIVDA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · JAKAFI · JEMPERLI · Jivi · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MARQIBO · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for nurse practitioner - adult health in FL.

Looking for a nurse practitioner - adult health in Naples?
Compare nurse practitioner - adult healths in the Naples area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - adult healths nearby

Geographic Context

Nurse Practitioner - Adult Healths within 10 mi
34
Per 100K population
8.8
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Guerrero is a nurse practitioner - adult health, and high industry engagement (low-engagement, top 3%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Guerrero receive payments from pharmaceutical companies?
Yes. Dr. Guerrero received a total of $9,400 from 74 companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Guerrero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →